Published in Peptides on January 13, 2016
The impacts of age and frailty on heart rate and sinoatrial node function. J Physiol (2016) 0.95
Reproductive age-associated fibrosis in the stroma of the mammalian ovary. Reproduction (2016) 0.85
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications. Can J Cardiol (2016) 0.80
Renal Aging: Causes and Consequences. J Am Soc Nephrol (2016) 0.75
Atrial structure, function and arrhythmogenesis in aged and frail mice. Sci Rep (2017) 0.75
Innovative Therapeutics: Designer Natriuretic Peptides. JACC Basic Transl Sci (2016) 0.75
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest (2000) 4.79
The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res (2006) 4.38
TGF-beta signaling in renal disease. J Am Soc Nephrol (2002) 4.21
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol (1997) 4.09
Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (1986) 3.37
Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res (2002) 2.98
Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res (2007) 2.32
Functional structure and composition of the extracellular matrix. J Pathol (2003) 2.10
Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol (2006) 2.02
Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res (1990) 1.89
The aging kidney. Kidney Int (2008) 1.85
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res (2005) 1.79
The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide. Hypertension (2010) 1.74
Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol (1997) 1.72
Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol (1984) 1.71
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol (2004) 1.67
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair (2012) 1.65
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J (2012) 1.58
Aging and Cardiac Fibrosis. Aging Dis (2011) 1.58
High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1. Mol Biol Cell (2011) 1.55
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2002) 1.45
Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology (2003) 1.40
Collagen accumulation in heart ventricles as a function of growth and aging. Cardiovasc Res (1989) 1.33
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J (2006) 1.31
Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension (1995) 1.29
Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int (2000) 1.26
Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol (1995) 1.22
Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res (2015) 1.20
Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension (2000) 1.19
Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature (1985) 1.17
Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). J Card Fail (2007) 1.16
Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J (2013) 1.08
Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure. J Cell Mol Med (2005) 1.06
Aging-associated changes in renal extracellular matrix. Am J Pathol (1995) 1.06
Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol (1995) 1.04
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure. Circ Heart Fail (2013) 1.02
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure. J Card Fail (2006) 0.99
Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem (1996) 0.98
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail (2014) 0.98
Current Inbred and Hybrid Rat and Mouse Models for Gereontological Research. ILAR J (1997) 0.95
Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex. J Gerontol A Biol Sci Med Sci (2000) 0.95
Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul Pept (2009) 0.94
Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome. Am J Physiol Heart Circ Physiol (2012) 0.94
Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo. Circulation (2000) 0.91
Age-related nephropathy in the Fischer 344 rat is associated with overexpression of collagens and collagen-binding heat shock protein 47. Cell Tissue Res (1998) 0.89
Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging. Am J Physiol Renal Physiol (2011) 0.88
Cardiac micro-computed tomography imaging of the aging coronary vasculature. Circ Cardiovasc Imaging (2012) 0.86
Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from disease. J Gerontol A Biol Sci Med Sci (1996) 0.86
Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling. Endocrinology (2007) 0.84
A direct microassay for aldosterone in plasma extracts. J Clin Endocrinol Metab (1978) 0.84
Natriuretic peptides and cardio-renal disease. Int J Cardiol (2014) 0.84
Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation. Circ Heart Fail (2014) 0.81
Alterations in atrial natriuretic peptide (ANP) secretion and renal effects in aging. J Gerontol A Biol Sci Med Sci (1997) 0.80
The effect of aging on ANP levels in the plasma, heart, and brain of rats. J Gerontol A Biol Sci Med Sci (1997) 0.79
Continuos intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat. Biochem Biophys Res Commun (2008) 0.77
Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling. Clin Chim Acta (2014) 0.76